文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

多功能硫酸葡聚糖包被的重组高密度脂蛋白靶向巨噬细胞并促进有益的抗动脉粥样硬化机制。

Multifunctional Dextran Sulfate-Coated Reconstituted High Density Lipoproteins Target Macrophages and Promote Beneficial Antiatherosclerotic Mechanisms.

作者信息

Zhao Yi, Jiang Cuiping, He Jianhua, Guo Qing, Lu Jing, Yang Yun, Zhang Wenli, Liu Jianping

机构信息

Department of Pharmaceutics, China Pharmaceutical University , Nanjing 210009, PR China.

出版信息

Bioconjug Chem. 2017 Feb 15;28(2):438-448. doi: 10.1021/acs.bioconjchem.6b00600. Epub 2017 Jan 5.


DOI:10.1021/acs.bioconjchem.6b00600
PMID:28004910
Abstract

An atorvastatin calcium (AT)-loaded dextran sulfate (DXS)-coated core-shell reconstituted high density lipoprotein (rHDL), termed AT-DXS-LP-rHDL, was developed for targeted drug delivery to macrophages and suppression of inflammation via the high affinity of DXS with scavenge receptor class AI (SR-AI) as well as depletion of intracellular cholesterol by apolipoprotein A-I (apoA-I)-mediated cholesterol efflux. These core-shell nanoparticles comprising an AT-loaded negatively charged poly(lactide-co-glycolide) (PLGA) core and a cationic lipid bilayer shell were prepared by nanoprecipitation method followed by thin film hydration and extrusion. The nanoparticles were further functionalized with apoA-I and DXS via sodium cholate mediation and electrostatic interaction, respectively. The core-shell structure and the surface coating of apoA-I and DXS were verified by the increased particle size, inverted zeta potential, and reduced in vitro drug release rate. The TEM image further confirmed the entrapment of the PLGA nanoparticles in the aqueous interior of the liposomes. In vitro cell viability assay showed the biocompatibility of the AT-loaded nanocarriers. The cellular uptake study illustrated that the targeting efficacy to macrophages increased in the following order: PLGA nanoparticles (P-NP), core-shell nanoparticles (LP-NP), core-shell rHDL (LP-rHDL), and DXS-LP-rHDL. Moreover, cellular drug efficacy of AT-loaded nanoparticles in preventing macrophage-derived foam cell formation and inflammation such as intracellular lipid deposition, cholesterol esters content, DiI-oxLDL uptake, cholesterol efflux, and secretion of TNF-α, IL-6, and IL-10 was much better than that of the drug-free nanoparticles, consistent with the results of cellular uptake study. Collectively, AT-DXS-LP-rHDL, as multifunctional carriers, could not only deliver more drug to macrophages, but also present antiatherogenic actions of the biofunctional nanocarriers through damping oxidized low density lipoproteins (oxLDL) uptake and promoting cholesterol efflux.

摘要

开发了一种载有阿托伐他汀钙(AT)的硫酸葡聚糖(DXS)包被的核壳型重组高密度脂蛋白(rHDL),称为AT-DXS-LP-rHDL,用于通过DXS与A类清道夫受体(SR-AI)的高亲和力以及载脂蛋白A-I(apoA-I)介导的胆固醇外流来消耗细胞内胆固醇,从而将药物靶向递送至巨噬细胞并抑制炎症。这些核壳纳米颗粒由负载AT的带负电荷的聚(丙交酯-共-乙交酯)(PLGA)核和阳离子脂质双层壳组成,通过纳米沉淀法制备,随后进行薄膜水化和挤压。纳米颗粒分别通过胆酸钠介导和静电相互作用用apoA-I和DXS进一步功能化。核壳结构以及apoA-I和DXS的表面包被通过粒径增加、zeta电位反转和体外药物释放速率降低得到证实。透射电镜图像进一步证实了PLGA纳米颗粒被包裹在脂质体的水性内部。体外细胞活力测定显示了载有AT的纳米载体的生物相容性。细胞摄取研究表明,对巨噬细胞的靶向效力按以下顺序增加:PLGA纳米颗粒(P-NP)、核壳纳米颗粒(LP-NP)、核壳rHDL(LP-rHDL)和DXS-LP-rHDL。此外,载有AT的纳米颗粒在预防巨噬细胞衍生的泡沫细胞形成和炎症方面的细胞药物效力,如细胞内脂质沉积、胆固醇酯含量、DiI-氧化低密度脂蛋白摄取、胆固醇外流以及肿瘤坏死因子-α、白细胞介素-6和白细胞介素-10的分泌,比无药物纳米颗粒要好得多,这与细胞摄取研究结果一致。总体而言,AT-DXS-LP-rHDL作为多功能载体,不仅可以向巨噬细胞递送更多药物,还可以通过抑制氧化低密度脂蛋白(oxLDL)摄取和促进胆固醇外流来呈现生物功能纳米载体的抗动脉粥样硬化作用。

相似文献

[1]
Multifunctional Dextran Sulfate-Coated Reconstituted High Density Lipoproteins Target Macrophages and Promote Beneficial Antiatherosclerotic Mechanisms.

Bioconjug Chem. 2017-2-15

[2]
Plaque-hyaluronidase-responsive high-density-lipoprotein-mimetic nanoparticles for multistage intimal-macrophage-targeted drug delivery and enhanced anti-atherosclerotic therapy.

Int J Nanomedicine. 2017-1-13

[3]
Shuttle/sink model composed of β-cyclodextrin and simvastatin-loaded discoidal reconstituted high-density lipoprotein for enhanced cholesterol efflux and drug uptake in macrophage/foam cells.

J Mater Chem B. 2020-2-19

[4]
Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.

Biochim Biophys Acta Mol Cell Biol Lipids. 2017-5-18

[5]
Function of different proportions of apolipoprotein A-I cysteine mutants and apolipoprotein A-V on recombinant high-density lipoproteins .

Biosci Rep. 2019-5-17

[6]
Endocytic recycling as cellular trafficking fate of simvastatin-loaded discoidal reconstituted high-density lipoprotein to coordinate cholesterol efflux and drug influx.

Nanomedicine. 2021-2

[7]
Evaluation of the Combined Effect of Recombinant High-Density Lipoprotein Carrier and the Encapsulated Lovastatin in RAW264.7 Macrophage Cells Based on the Median-Effect Principle.

Mol Pharm. 2018-2-5

[8]
Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-IMilano dimer.

Biochemistry. 1999-12-7

[9]
Biofunctional Polymer-Lipid Hybrid High-Density Lipoprotein-Mimicking Nanoparticles Loading Anti-miR155 for Combined Antiatherogenic Effects on Macrophages.

Biomacromolecules. 2017-8-3

[10]
Structure and remodeling behavior of drug-loaded high density lipoproteins and their atherosclerotic plaque targeting mechanism in foam cell model.

Int J Pharm. 2011-7-30

引用本文的文献

[1]
DS-Modified Paeoniflorin pH-Responsive Lipid-Polymer Hybrid Nanoparticles for Targeted Macrophage Polarization in a Rat Model of Rheumatoid Arthritis.

Int J Nanomedicine. 2025-7-12

[2]
Golden Tandem of Photothermal Ablation and Simultaneous Anti-Inflammation in One Nanoparticle for Activated Macrophage-Targeted Atherosclerosis Treatment.

Int J Nanomedicine. 2025-2-7

[3]
Biomimetic nanoparticles targeting atherosclerosis for diagnosis and therapy.

Smart Med. 2023-8-3

[4]
Advances in the treatment of atherosclerosis with ligand-modified nanocarriers.

Exploration (Beijing). 2023-12-7

[5]
Curcumin Equipped Nanozyme-Like Metal-Organic Framework Platform for the Targeted Atherosclerosis Treatment with Lipid Regulation and Enhanced Magnetic Resonance Imaging Capability.

Adv Sci (Weinh). 2024-7

[6]
In Vitro Targeted Delivery of Simvastatin and Niacin to Macrophages Using Mannan-Grafted Magnetite Nanoparticles.

ACS Omega. 2023-12-18

[7]
Macrophage-based therapeutic approaches for cardiovascular diseases.

Basic Res Cardiol. 2024-2

[8]
Lipid-laden foam cells in the pathology of atherosclerosis: shedding light on new therapeutic targets.

Expert Opin Ther Targets. 2023

[9]
Hybrid Lymphatic Drug Delivery Vehicles as a New Avenue for Targeted Therapy: Lymphatic Trafficking, Applications, Challenges, and Future Horizons.

J Membr Biol. 2023-6

[10]
Targeted Therapy of Atherosclerosis Vulnerable Plaque by ROS-Scavenging Nanoparticles and MR/Fluorescence Dual-Modality Imaging Tracing.

Int J Nanomedicine. 2022

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索